Raised PSA:
Do I Need a Prostate Biopsy?
Understanding PSA levels, MRI findings, PSA density, and prostate cancer risk.
A raised PSA level does not automatically mean you need a biopsy. Learn how PSA results, prostate MRI, risk calculators, and additional tests help determine whether further investigation is necessary.
Raised PSA: Key Points
- PSA is not a cancer test
- PSA above 2.5 ng/mL may warrant further assessment
- MRI and PSA density improve decision-making
- Risk calculators help estimate prostate cancer risk
- Not everyone with a raised PSA needs a biopsy
Do I Need a Prostate Biopsy?
An elevated prostate-specific antigen (PSA) level can be concerning. Many men assume that a high PSA result means they have prostate cancer or that a biopsy is immediately necessary.
In reality, PSA is only one part of the assessment.
Modern prostate cancer screening combines PSA testing with other tools, including MRI, PSA density, additional blood tests, and validated risk calculators. This approach helps identify men who may benefit from a prostate biopsy while reducing unnecessary procedures.
Understanding what your PSA result means can help you make informed decisions about the next steps.
A raised PSA level does not automatically mean you need a prostate biopsy.
Modern assessment combines PSA testing with MRI, PSA density, additional blood tests, and risk calculators to determine whether a biopsy is necessary.
What Is PSA?
PSA stands for prostate-specific antigen, a protein produced by both normal and abnormal prostate cells.
A PSA blood test measures the amount of PSA circulating in the bloodstream. Although PSA is commonly used to assess prostate cancer risk, it is not a cancer test.
Several conditions can increase PSA levels, including:
- Benign enlargement of the prostate (benign prostatic hyperplasia or BPH)
- Prostate inflammation or infection (prostatitis)
- Urinary tract infection
- Recent ejaculation
- Vigorous cycling
- Recent urinary catheterisation or cystoscopy
- Recent prostate examination or procedure
- Prostate cancer
A single elevated PSA result rarely provides enough information to determine whether a biopsy is needed.
What PSA Level Requires Further Assessment?
There is no single PSA level that clearly separates normal from abnormal.
Historically, a PSA level above 4.0 ng/mL was often used as a threshold for further investigation. Today, many specialists recognise that clinically significant prostate cancer can occur at lower PSA levels, particularly in younger men or those with additional risk factors.
Some centres use a PSA level above 2.5 ng/mL as a trigger for further assessment.
However, a PSA level above 2.5 ng/mL does not automatically mean you need a prostate biopsy.
Instead, it may indicate that further evaluation is needed to better understand your individual risk.
This assessment may include:
- Repeat PSA testing
- Review of PSA trends over time
- Digital rectal examination (DRE)
- Multiparametric MRI (mpMRI)
- PSA density
- Additional blood tests such as free PSA or the Prostate Health Index (PHI)
- Validated PSA risk calculators
- Review of family history and other risk factors
The decision to proceed with a prostate biopsy should be based on your overall risk profile rather than a single PSA result.
Why PSA Alone Should Not Determine Whether You Need a Biopsy
PSA is most useful when interpreted alongside other information.
Your urologist may consider:
- Your age
- Family history of prostate cancer
- Ethnicity
- Previous PSA results
- How quickly PSA has changed over time
- Findings on digital rectal examination
- Prostate size
- PSA density
- Percentage of free PSA
- Prostate Health Index (PHI)
- MRI findings
This approach provides a more accurate assessment of your risk and helps avoid unnecessary biopsies.
What Is a PSA Risk Calculator?
A PSA risk calculator estimates the likelihood of finding prostate cancer, particularly clinically significant cancer that may require treatment.
These calculators combine several pieces of information rather than relying on PSA alone.
Commonly used risk calculators include:
- Prostate Cancer Prevention Trial (PCPT) Risk Calculator
- Prostate Biopsy Collaborative Group (PBCG) Risk Calculator
- European Randomized Study of Screening for Prostate Cancer (ERSPC) Risk Calculator
Information entered into these calculators may include:
- Age
- PSA level
- Family history
- Ethnicity
- Digital rectal examination findings
- Previous biopsy results
- MRI findings
Risk calculators can support shared decision-making between patients and their doctors.
However, they should not replace consultation with a urologist.
What Is PSA Density?
PSA density compares your PSA level with the size of your prostate.
It is calculated by dividing the PSA level by the prostate volume, which is usually measured during a prostate MRI scan or ultrasound.
PSA density = PSA ÷ prostate volume
Men with larger prostates often have higher PSA levels because there is more prostate tissue producing PSA.
A higher PSA density may indicate an increased risk of clinically significant prostate cancer.
Although there is no absolute cutoff, a PSA density above 0.15 ng/mL/cm³ is often considered an important factor when deciding whether further investigation is needed.
How Can MRI Help Avoid Unnecessary Biopsies?
Multiparametric MRI (mpMRI) has changed how elevated PSA levels are assessed.
An MRI scan can:
- Identify suspicious areas within the prostate
- Estimate the risk of clinically significant cancer
- Measure prostate size accurately
- Help calculate PSA density
- Reduce unnecessary biopsies
- Guide targeted biopsies when needed
MRI findings are usually reported using the PI-RADS scoring system, which ranges from 1 to 5.
Higher PI-RADS scores indicate a greater likelihood of clinically significant prostate cancer.
Although MRI is an important tool, it cannot detect every cancer. Some men with a normal MRI may still require further assessment.
When Is a Prostate Biopsy Recommended?
A prostate biopsy may be recommended when one or more of the following are present:
- Persistently elevated PSA levels
- Rising PSA over time
- Abnormal digital rectal examination findings
- Suspicious MRI findings
- Elevated PSA density
- High-risk results from validated risk calculators
- Strong family history of prostate cancer
The decision to proceed with a biopsy should be based on a discussion between you and your urologist, taking into account your overall health, preferences, and individual risk.
What Happens During a Prostate Biopsy?
If a biopsy is recommended, many centres now favour the transperineal approach.
A transperineal prostate biopsy involves passing biopsy needles through the skin between the scrotum and anus rather than through the rectum.
This approach may offer several advantages:
- Lower risk of infection compared with traditional transrectal biopsy
- Improved access to all areas of the prostate
- MRI-targeted sampling of suspicious areas
- More accurate diagnosis of clinically significant cancer
The procedure is commonly performed under local or general anaesthesia, depending on the technique used.
Most men return home on the same day.
Should PSA Be Repeated Before a Biopsy?
In some situations, repeating the PSA test after several weeks may be appropriate.
This may be considered if:
- You recently had a urinary tract infection
- You have symptoms of prostatitis
- You had a recent urinary procedure
- The initial PSA result was unexpected
- Temporary factors such as recent ejaculation or vigorous cycling may have affected the result
Repeating the test under standardised conditions can help avoid unnecessary investigations.
Questions to Ask After an Elevated PSA Result
If your PSA level is raised, you may wish to ask:
- Should my PSA test be repeated?
- Would additional blood tests such as free PSA or PHI be helpful?
- Do I need a prostate MRI?
- What is my PSA density?
- Can a validated risk calculator estimate my risk?
- What are the benefits and risks of a prostate biopsy?
Understanding these factors can help you make informed decisions about your care.
Frequently Asked Questions
What is considered a normal PSA level?
There is no single PSA level that is considered normal for every man.
PSA levels vary with age, prostate size, ethnicity, and individual factors. Some men with a PSA below 2.5 ng/mL may still have prostate cancer, while many men with higher PSA levels do not.
Your PSA result should always be interpreted in the context of your age, symptoms, medical history, and other risk factors.
Does a PSA above 2.5 ng/mL mean I need a biopsy?
No. A PSA level above 2.5 ng/mL may prompt further assessment, particularly in younger men or those with additional risk factors.
Additional tests such as repeat PSA testing, MRI, PSA density, and risk calculators can help determine whether a prostate biopsy is necessary.
Does a PSA above 4 ng/mL mean I have prostate cancer?
No. A PSA level above 4 ng/mL increases the likelihood of prostate cancer, but many non-cancerous conditions can also raise PSA levels.
Benign prostate enlargement, prostatitis, urinary tract infections, recent ejaculation, cycling, and recent urinary procedures may all affect PSA results.
Why might my PSA level be high if I do not have prostate cancer?
PSA is produced by normal prostate tissue as well as cancer cells.
Common causes of an elevated PSA include:
- Benign enlargement of the prostate (BPH)
- Prostatitis
- Urinary tract infection
- Recent ejaculation
- Vigorous exercise such as cycling
- Recent catheterisation or cystoscopy
- Recent prostate examination or biopsy
Your doctor may recommend repeating the PSA test after these factors have resolved.
Should I repeat my PSA test before having a biopsy?
In some cases, yes.
Repeating the PSA test after several weeks may be helpful if you recently had an infection, urinary procedure, ejaculation, or vigorous exercise that could have temporarily increased your PSA level.
A repeat test can confirm whether the PSA elevation is persistent before deciding on further investigations.
What is PSA density?
PSA density compares your PSA level with the size of your prostate.
It is calculated by dividing the PSA level by the prostate volume measured on MRI or ultrasound.
Higher PSA density values may indicate a greater risk of clinically significant prostate cancer.
What is free PSA and how is it different from total PSA?
PSA circulates in the blood in two forms: attached to proteins and unattached, known as free PSA.
The percentage of free PSA can help estimate prostate cancer risk in men with borderline or moderately elevated PSA levels.
Lower percentages of free PSA are generally associated with a higher likelihood of prostate cancer.
What is the Prostate Health Index (PHI)?
PHI is a blood test that combines total PSA, free PSA, and [-2]proPSA to improve the assessment of prostate cancer risk.
It may help identify men who are more likely to have clinically significant prostate cancer and reduce unnecessary biopsies.
How quickly should PSA levels rise?
Changes in PSA over time, sometimes called PSA velocity, can provide useful information.
A steadily rising PSA level may warrant further investigation, even if the absolute PSA value remains relatively low.
Your doctor will interpret PSA trends alongside MRI findings, PSA density, and other risk factors.
Can I use an online PSA risk calculator myself?
Online PSA risk calculators can provide useful estimates of prostate cancer risk.
However, they do not replace medical advice. Results should be interpreted alongside your medical history, examination findings, PSA density, and MRI results.
Can MRI replace a prostate biopsy?
MRI can help determine whether a biopsy is necessary and can reduce unnecessary procedures.
However, MRI cannot completely exclude prostate cancer, particularly in men with persistently elevated PSA levels or high PSA density.
Is a transperineal biopsy safer than a transrectal biopsy?
The transperineal approach is associated with a lower risk of infection because the biopsy needles do not pass through the rectum.
It also allows better access to certain areas of the prostate and can improve the accuracy of MRI-targeted biopsies.
References
This page has been developed using recommendations and evidence from international urological guidelines and peer-reviewed literature, including:
- European Association of Urology (EAU) Guidelines on Prostate Cancer and Prostate Cancer Early Detection
- American Urological Association (AUA) Guideline on Early Detection of Prostate Cancer
- National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Prostate Cancer Early Detection
- European Randomized Study of Screening for Prostate Cancer (ERSPC) Risk Calculator publications
- Prostate Cancer Prevention Trial (PCPT) Risk Calculator publications
- Prostate Imaging Reporting and Data System (PI-RADS) Version 2.1
Clinical guidelines are regularly updated. Recommendations may vary depending on individual circumstances, local practice patterns, and emerging evidence.
Last reviewed: June 2026
Medical reviewer: Dr Roger Anthony Idi, Consultant Urologist
What Should You Do After a Raised PSA Result?
Understanding a PSA result often requires more than a single number.
A comprehensive assessment may include repeat PSA testing, prostate MRI, PSA density, additional blood tests, and validated risk calculators to determine whether a prostate biopsy is necessary.
Discussing your results with a urologist can help you understand your individual risk and the most appropriate next steps.